Cargando…

lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516

INTRODUCTION: Breast cancer is a serious threat to human health. It is meaningful to study the pathogenesis of breast cancer. lncRNAs have been found to play vital roles in numerous biological processes including development, immunology and cancer. METHODS: qRT-PCR was performed to examine the expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhuo, Xu, Ruqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457826/
https://www.ncbi.nlm.nih.gov/pubmed/32922076
http://dx.doi.org/10.2147/CMAR.S249296
_version_ 1783576074815275008
author Wang, Zhuo
Xu, Ruqing
author_facet Wang, Zhuo
Xu, Ruqing
author_sort Wang, Zhuo
collection PubMed
description INTRODUCTION: Breast cancer is a serious threat to human health. It is meaningful to study the pathogenesis of breast cancer. lncRNAs have been found to play vital roles in numerous biological processes including development, immunology and cancer. METHODS: qRT-PCR was performed to examine the expressions of PART1 and miR-4516. CCK-8 assay, colony formation assay and transwell assay were used to examine the progression of breast cancer cells. RESULTS: In this study, we showed that lncRNA PART1 was highly expressed in breast cancer cells. Knockdown of PART1 induced decreased proliferation, invasion and migration of breast cancer cells. Moreover, we found that PART1 can bind to miR-4516 directly. We also found that inhibition of miR-4516 could rescue the decreased proliferation, migration and invasion of breast cancer cells induced by knockdown of PART1. DISCUSSION: lncRNA PART1 and miR-4516 were proven to be involved in the progression of many cancers. However, the roles of lncRNA PART1 and miR-4516 in the regulation of breast cancer remain unknown. Here, we demonstrated that PART1 can bind to miR-4516 to decrease the expression of miR-4516 and promote the development of breast cancer.
format Online
Article
Text
id pubmed-7457826
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-74578262020-09-11 lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516 Wang, Zhuo Xu, Ruqing Cancer Manag Res Original Research INTRODUCTION: Breast cancer is a serious threat to human health. It is meaningful to study the pathogenesis of breast cancer. lncRNAs have been found to play vital roles in numerous biological processes including development, immunology and cancer. METHODS: qRT-PCR was performed to examine the expressions of PART1 and miR-4516. CCK-8 assay, colony formation assay and transwell assay were used to examine the progression of breast cancer cells. RESULTS: In this study, we showed that lncRNA PART1 was highly expressed in breast cancer cells. Knockdown of PART1 induced decreased proliferation, invasion and migration of breast cancer cells. Moreover, we found that PART1 can bind to miR-4516 directly. We also found that inhibition of miR-4516 could rescue the decreased proliferation, migration and invasion of breast cancer cells induced by knockdown of PART1. DISCUSSION: lncRNA PART1 and miR-4516 were proven to be involved in the progression of many cancers. However, the roles of lncRNA PART1 and miR-4516 in the regulation of breast cancer remain unknown. Here, we demonstrated that PART1 can bind to miR-4516 to decrease the expression of miR-4516 and promote the development of breast cancer. Dove 2020-08-24 /pmc/articles/PMC7457826/ /pubmed/32922076 http://dx.doi.org/10.2147/CMAR.S249296 Text en © 2020 Wang and Xu. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Zhuo
Xu, Ruqing
lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516
title lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516
title_full lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516
title_fullStr lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516
title_full_unstemmed lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516
title_short lncRNA PART1 Promotes Breast Cancer Cell Progression by Directly Targeting miR-4516
title_sort lncrna part1 promotes breast cancer cell progression by directly targeting mir-4516
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457826/
https://www.ncbi.nlm.nih.gov/pubmed/32922076
http://dx.doi.org/10.2147/CMAR.S249296
work_keys_str_mv AT wangzhuo lncrnapart1promotesbreastcancercellprogressionbydirectlytargetingmir4516
AT xuruqing lncrnapart1promotesbreastcancercellprogressionbydirectlytargetingmir4516